{"transactions":[{"id":700776,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-30T20:27:35.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":18750,"derivative":{"exercise_price":2.14,"expiration_date":"2036-07-28","underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001873463-26-000002","document":"form4-07302026_080726.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000187346326000002/form4-07302026_080726.xml","form_type":"4"}},{"id":700775,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-30T20:27:35.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":53375,"source":{"system":"sec-edgar","filing":"0001873463-26-000002","document":"form4-07302026_080726.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000187346326000002/form4-07302026_080726.xml","form_type":"4"}},{"id":1049958,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-04T01:06:31.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":61000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in three equal annual installments beginning on September 2, 2026."}],"balance_after":61000,"derivative":{"exercise_price":2.04,"expiration_date":"2035-09-02","underlying":"Class A Common Stock","underlying_shares":61000},"source":{"system":"sec-edgar","filing":"0001415889-25-023618","document":"form4-09042025_010927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000141588925023618/form4-09042025_010927.xml","form_type":"4"}},{"id":1049957,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-09-04T01:06:31.000Z","date":"2025-09-02","kind":"grant","planned":false,"acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in three equal annual installments beginning on September 2, 2026."}],"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001415889-25-023618","document":"form4-09042025_010927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000141588925023618/form4-09042025_010927.xml","form_type":"4"}},{"id":1873485,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CFO"}}],"security":"Restricted Stock Unit","published_at":"2023-05-31T20:19:39.000Z","date":"2022-07-01","kind":"exercise","planned":false,"acquired":false,"shares":7396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total shares underlying the restricted stock units vest in quarterly installments beginning on July 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":110954,"derivative":{"underlying":"Class A Common Stock","underlying_shares":7396},"source":{"system":"sec-edgar","filing":"0001209191-23-033109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919123033109/doc4.xml","form_type":"4"}},{"id":1873484,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CFO"}}],"security":"Class A Common Stock","published_at":"2023-05-31T20:19:39.000Z","date":"2022-07-05","kind":"sale","planned":false,"acquired":false,"shares":2296,"price":1.3187,"value":3027.7352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.215 to $1.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":206886,"source":{"system":"sec-edgar","filing":"0001209191-23-033109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919123033109/doc4.xml","form_type":"4"}},{"id":1873483,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Former CFO"}}],"security":"Class A Common Stock","published_at":"2023-05-31T20:19:39.000Z","date":"2022-07-01","kind":"exercise","planned":false,"acquired":true,"shares":7396,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":209182,"source":{"system":"sec-edgar","filing":"0001209191-23-033109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919123033109/doc4.xml","form_type":"4"}},{"id":2189774,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T23:53:28.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":625000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-22-045315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122045315/doc4.xml","form_type":"4"}},{"id":2189773,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Class A Common Stock","published_at":"2022-08-10T23:53:28.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":20245,"price":1.9865,"value":40216.6925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.89 to $1.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":244041,"source":{"system":"sec-edgar","filing":"0001209191-22-045315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122045315/doc4.xml","form_type":"4"}},{"id":2189772,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CFO"}}],"security":"Class A Common Stock","published_at":"2022-08-10T23:53:28.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":264286,"source":{"system":"sec-edgar","filing":"0001209191-22-045315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122045315/doc4.xml","form_type":"4"}},{"id":2273681,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-05-13T00:22:27.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":687500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-22-028689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122028689/doc4.xml","form_type":"4"}},{"id":2273680,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-13T00:22:27.000Z","date":"2022-05-10","kind":"sale","acquired":false,"shares":19515,"price":2.46,"value":48006.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":201786,"source":{"system":"sec-edgar","filing":"0001209191-22-028689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122028689/doc4.xml","form_type":"4"}},{"id":2273679,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-05-13T00:22:27.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":221301,"source":{"system":"sec-edgar","filing":"0001209191-22-028689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122028689/doc4.xml","form_type":"4"}},{"id":2300503,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-08T21:08:28.000Z","date":"2022-04-06","kind":"sale","acquired":false,"shares":1284,"price":2.9101,"value":3736.5684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover certain tax obligation in connection with the stock bonus granted to the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.91 to $2.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":158801,"source":{"system":"sec-edgar","filing":"0001209191-22-023878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122023878/doc4.xml","form_type":"4"}},{"id":2302720,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-04-06T21:16:19.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":118350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":118350,"derivative":{"underlying":"Class A Common Stock","underlying_shares":118350},"source":{"system":"sec-edgar","filing":"0001209191-22-023517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122023517/doc4.xml","form_type":"4"}},{"id":2302719,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-04-06T21:16:19.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":205469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"6.25% vest in quarterly installments over the four-year period commencing on April 1, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":205469,"derivative":{"exercise_price":3.05,"expiration_date":"2032-04-03","underlying":"Class A Common Stock","underlying_shares":205469},"source":{"system":"sec-edgar","filing":"0001209191-22-023517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122023517/doc4.xml","form_type":"4"}},{"id":2302718,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-06T21:16:19.000Z","date":"2022-04-04","kind":"grant","acquired":true,"shares":3896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The indicated shares were issued to the Reporting Person as a stock bonus.  The stock bonus was fully-vested as of the date of issuance."}],"balance_after":160085,"source":{"system":"sec-edgar","filing":"0001209191-22-023517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122023517/doc4.xml","form_type":"4"}},{"id":2404604,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-02-11T01:30:15.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":750000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-22-008637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122008637/doc4.xml","form_type":"4"}},{"id":2404603,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-11T01:30:15.000Z","date":"2022-02-10","kind":"sale","acquired":false,"shares":21735,"price":3.5998,"value":78241.653,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.59 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":156189,"source":{"system":"sec-edgar","filing":"0001209191-22-008637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122008637/doc4.xml","form_type":"4"}},{"id":2404602,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-02-11T01:30:15.000Z","date":"2022-02-08","kind":"exercise","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":177924,"source":{"system":"sec-edgar","filing":"0001209191-22-008637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919122008637/doc4.xml","form_type":"4"}},{"id":2475843,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-12-14T00:08:11.000Z","date":"2021-12-09","kind":"grant","acquired":true,"shares":197607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration, granted pursuant to the terms of that certain Agreement and Plan of Merger, dated as of February 9, 2021 (as amended, the \"Merger Agreement\"), by and among CM Life Sciences, Inc., S-IV Sub, Inc. and Mount Sinai Genomics, Inc. d/b/a Sema4. In addition, in the event that any similar RSUs are forfeited (for example, as a result of the recipient no longer being an employee of the Issuer), the Merger Agreement provides for the shares underlying such forfeited RSUs to become available for issuance to other RSU recipients.  Therefore, each RSU also represents to right to receive additional shares of the Issuer's Class A Common Stock from this \"forfeiture pool\".  The number of shares of the Issuer's Class A Common Stock that may be issued to the Reporting Person pursuant to the \"forfeiture pool\" is not determinable at this time."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"[cont'd from footnote 1] Any shares of the Issuer's Class A Common Stock ultimately issued to the Reporting Person in respect of each RSU will be reported in a subsequent filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement.  The service requirement is deemed satisfied as of the grant date with respect to 24,701 of the RSUs, and will be satisfied with respect to the remainder of the RSUs over 14 quarterly periods, subject to the Reporting Person's continued service to the Issuer on each service-based vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting of the RSUs is conditioned on the satisfaction of both a service requirement and a market-based requirement.  The service requirement is deemed satisfied as of the grant date with respect to 24,701 of the RSUs, and will be satisfied with respect to the remainder of the RSUs over 14 quarterly periods, subject to the Reporting Person's continued service to the Issuer on each service-based vesting date."}],"balance_after":197607,"derivative":{"underlying":"Class A Common Stock","underlying_shares":197607},"source":{"system":"sec-edgar","filing":"0001209191-21-069330","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121069330/doc4.xml","form_type":"4"}},{"id":2486446,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T23:56:49.000Z","date":"2021-12-01","kind":"tax_withholding","acquired":false,"shares":215,"price":5.52,"value":1186.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares required to be sold by the Reporting Person to cover certain tax obligation in connection with the stock bonus granted to the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":115424,"source":{"system":"sec-edgar","filing":"0001209191-21-067986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121067986/doc4.xml","form_type":"4"}},{"id":2486445,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-03T23:56:49.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":618,"price":6.05,"value":3738.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The indicated shares were issued to Reporting Person as a stock bonus in connection with the elimination of Issuer's sabbatical leave program, in which all employees of Issuer hired on or before June 30, 2021 were provided an opportunity to receive a stock bonus in lieu of their continued eligibility to take sabbatical leave.  The stock bonus was fully vested as of the date of issuance."}],"balance_after":115639,"source":{"system":"sec-edgar","filing":"0001209191-21-067986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121067986/doc4.xml","form_type":"4"}},{"id":2490858,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-12-02T01:08:04.000Z","date":"2021-11-29","kind":"sale","acquired":false,"shares":12115,"price":6.63,"value":80322.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.  The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.59 to $6.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":115021,"source":{"system":"sec-edgar","filing":"0001209191-21-067376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121067376/doc4.xml","form_type":"4"}},{"id":2518073,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-11-10T23:54:25.000Z","date":"2021-11-08","kind":"exercise","acquired":false,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vested on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":812500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-21-063952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121063952/doc4.xml","form_type":"4"}},{"id":2518072,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-10T23:54:25.000Z","date":"2021-11-08","kind":"sale","acquired":false,"shares":19516,"price":8.4902,"value":165694.7432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":127136,"source":{"system":"sec-edgar","filing":"0001209191-21-063952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121063952/doc4.xml","form_type":"4"}},{"id":2518071,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-10T23:54:25.000Z","date":"2021-11-08","kind":"exercise","acquired":true,"shares":62500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":146652,"source":{"system":"sec-edgar","filing":"0001209191-21-063952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121063952/doc4.xml","form_type":"4"}},{"id":2529281,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-11-03T00:21:23.000Z","date":"2021-10-25","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vest on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/8th of the total shares vested on October 25, 2021, 1/16th of the total shares vest on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":875000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-21-062549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121062549/doc4.xml","form_type":"4"}},{"id":2529280,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T00:21:23.000Z","date":"2021-10-25","kind":"sale","acquired":false,"shares":40848,"price":7.54,"value":307993.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":84152,"source":{"system":"sec-edgar","filing":"0001209191-21-062549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121062549/doc4.xml","form_type":"4"}},{"id":2529279,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-11-03T00:21:23.000Z","date":"2021-10-25","kind":"exercise","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001209191-21-062549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121062549/doc4.xml","form_type":"4"}},{"id":2549514,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-10-06T01:43:26.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/8th of the total shares vest on October 25, 2021, 1/16th of the total shares vest on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"1/8th of the total shares vest on October 25, 2021, 1/16th of the total shares vest on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":1000000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001209191-21-059756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121059756/doc4.xml","form_type":"4"}},{"id":2549513,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":27800,"kind":"person","name":"Ro Isaac","position":1,"cik":"0001873463","reported_name":"Ro Isaac","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-06T01:43:26.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":578704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/8th of the total shares vest on October 25, 2021, 1/16th of the total shares vest on November 8, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on February 8, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":578704,"derivative":{"exercise_price":7.62,"expiration_date":"2031-09-30","underlying":"Class A Common Stock","underlying_shares":578704},"source":{"system":"sec-edgar","filing":"0001209191-21-059756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1873463/000120919121059756/doc4.xml","form_type":"4"}}]}